Literature DB >> 22927168

Smoothing the path: reducing biliary complications, addressing small-for-size syndrome, and making other adaptations to decrease the risk for living donor liver transplant recipients.

Arvinder S Soin1.   

Abstract

KEY POINTS: 1. Over the course of the past 2 decades, living donor liver transplantation (LDLT) has become increasingly successful because many of the technical issues plaguing it have been resolved. 2. Although donor safety remains a concern, most challenges related to the recipient's surgery are now better understood, and they appear surmountable. 3. The following concepts need to be addressed for optimal recipient outcomes to be achieved: a. Reduction of the risk of small-for-size syndrome in LDLT (ie, the management of 4 factors: the recipient status, the portal pressure and inflow, the venous outflow, and the graft-to-recipient weight ratio/graft quality). b. Reduction of the risk of surgical complications (biliary complications, reconstitution of the middle hepatic vein outflow in the right lobe graft, and safe hepatic artery and portal vein reconstruction). c. Other adaptations for improving recipient outcomes (adaptations related to LDLT and adaptations common to deceased donor liver transplantation and LDLT).
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22927168     DOI: 10.1002/lt.23541

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  8 in total

1.  Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-First report from India.

Authors:  Suneed Kumar; Nidhi Khandelwal; Abhaya Kumar; Kapildev Yadav; Swapnil Sharma; Shailesh Sable; Ashutosh Chauhan; Sorabh Kapoor; Vibha Varma; Jaydeep Palep; Vinay Kumaran
Journal:  Indian J Gastroenterol       Date:  2017-05-31

2.  Poor Performance Status Predicts Mortality After Living Donor Liver Transplantation.

Authors:  Narendra S Choudhary; Amey Sonavane; Neeraj Saraf; Sanjiv Saigal; Amit Rastogi; Prashant Bhangui; Srinivasan Thiagrajan; Sanjay K Yadav; Sujeet Saha; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2019-07-05

3.  Recurrent Hepatic Encephalopathy Due to Surgically Created Shunt During Living Donor Liver Transplantation.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Neeraj Saraf; Sanjay S Baijal; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2020-08-12

Review 4.  Liver Transplant Outcomes in India.

Authors:  Narendra S Choudhary; Prashant Bhangui; Arvinder S Soin
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-01-24

5.  Fast tracking in adult living donor liver transplantation: A case series of 15 patients.

Authors:  Pooja Bhangui; Prashant Bhangui; Nikunj Gupta; Annu Sarin Jolly; Seema Bhalotra; Nishant Sharma; A S Soin; Vijay Vohra
Journal:  Indian J Anaesth       Date:  2018-02

6.  Living-donor liver transplantation in Budd-Chiari syndrome with inferior vena cava complete thrombosis: A case report and review of the literature.

Authors:  Vinicius Rocha-Santos; Daniel Reis Waisberg; Rafael Soares Pinheiro; Lucas Souto Nacif; Rubens Macedo Arantes; Liliana Ducatti; Rodrigo Bronze Martino; Luciana Bertocco Haddad; Flavio Henrique Galvao; Wellington Andraus; Luiz Augusto Carneiro-D'Alburquerque
Journal:  World J Hepatol       Date:  2021-01-27

7.  Graft Inflow Modulation in Living-Donor Liver Transplantation: Hepatic Hemodynamic Changes in Splenic Artery Ligation and Splenectomy.

Authors:  Che-Min Su; Tsung-Ching Chou; Tsung-Han Yang; Yih-Jyh Lin
Journal:  Ann Transplant       Date:  2022-07-19       Impact factor: 1.479

8.  Living Donor Liver Transplantation Using Small-for-Size Grafts: Does Size Really Matter?

Authors:  Pulkit Sethi; Manoj Thillai; Binoj Sivasankarapillai Thankamonyamma; Shweta Mallick; Unnikrishnan Gopalakrishnan; Dinesh Balakrishnan; Ramachandran Narayana Menon; Sudhindran Surendran; Puneet Dhar; Sudheer Othiyil Vayoth
Journal:  J Clin Exp Hepatol       Date:  2017-06-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.